Aryl hydrocarbon receptor dynamics in esophageal squamous cell carcinoma: From immune modulation to therapeutic opportunities

doi:10.5493/wjem.v14.i3.96269

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-2)

Sum=0

Sep 20, 2024 (publication date) through Aug 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Exp Med. Sep 20, 2024; 14(3): 96269
Published online Sep 20, 2024. doi: 10.5493/wjem.v14.i3.96269

Open in New Tab Full Size Figure Download Figure

Figure 1 Aryl hydrocarbon receptor signaling in esophageal squamous cell carcinoma development and immune escape. This figure illustrates the multifaceted influence of aryl hydrocarbon receptor (AhR) signaling on esophageal squamous cell carcinoma (ESCC) development and immune escape. Activation of AhR by environmental carcinogens or other ligands initiates a cascade of cellular processes that contribute to tumorigenesis. EMT: Epithelial-mesenchymal transition; NH3: Ammonia; PD-L1: Programmed death-ligand 1; ROS: Reactive oxygen species; TEPA: Triethylenetetramine.

Citation: Rahmati M, Moghtaderi H, Mohammadi S, Al-Harrasi A. Aryl hydrocarbon receptor dynamics in esophageal squamous cell carcinoma: From immune modulation to therapeutic opportunities. World J Exp Med 2024; 14(3): 96269
URL: https://www.wjgnet.com/2220-315x/full/v14/i3/96269.htm
DOI: https://dx.doi.org/10.5493/wjem.v14.i3.96269